Navigation Links
Molecule Discovery Might Help ALS Patients
Date:12/10/2009

Finding in mouse study could lead to treatment for the disease, researchers say

THURSDAY, Dec. 10 (HealthDay News) -- Researchers have identified a molecule that can reduce symptoms and prolong the life of mice with a type of amyotrophic lateral sclerosis (ALS).

The molecule, called microRNA-206 (miR-206), is produced naturally by skeletal muscles in response to nerve damage caused by ALS, also known as Lou Gehrig's disease. The molecule acts as a chemical signal to guide new nerve endings and maintain their interactions with muscles.

However, this research in mice suggests that miR-206 only works for a limited period of time. As nerves continue to die because of ALS, eventually surviving nerves can no longer compensate and symptoms such as muscle weakness begin to develop.

"While miR-206 initially prompts nearby surviving nerves to send new branches to the muscles, it only delays the inevitable," study senior author Eric Olson, chairman of molecular biology at the University of Texas Southwestern Medical Center, said in a university news release.

"Our findings correlate with the observation in ALS patients that the disease is nearly asymptomatic until a large fraction of motor neurons has died, at which point the few remaining ones can't compensate sufficiently," he explained. "These results provide a new perspective on the mechanisms of ALS. MiR-206 seems to sense nerve injury and promote regeneration."

These findings may help in efforts to develop drugs to treat ALS. Currently there is no cure or treatment to slow progression of the disease, which causes muscle weakness, paralysis and death.

"Because miR-206 only exists in skeletal muscle, a drug based on it might not affect other tissues. That limits its risk of side effects and is a key part of its appeal as a potential therapy," Olson added.

The study appears in the Dec. 11 issue of the journal Science.

More information

The ALS Association has more about amyotrophic lateral sclerosis.



-- Robert Preidt



SOURCE: University of Texas Southwestern Medical Center, news release, Dec. 10, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Wayne State Researchers Report a Possible Proofreading Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase
2. Molecules wrestle for supremacy in creation of superstructures
3. Molecule plays early role in nonsmoking lung cancer
4. Molecule Helps Leukemia Cells Hide From Immune System
5. Small Molecule Might Play Big Part in Lung Cancer
6. New role discovered for molecule important in development of the pancreas
7. Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway
8. Ready for relapse: Molecule helps breast cancer cells to survive in the bone marrow
9. LSUHSC research identifies enzyme that makes survival molecule for key vision cells
10. Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Concerning Prospect Therapeutics Incs. GCS-100 Molecule
11. Small molecule inhibitor shows promise in trastuzumab-resistant metastatic breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... ... A recent video posting of a new fidget product gathered online momentum as ... stress and anxiety. No one was more surprised than Think Ink Pen founders ... successful Kickstarter campaign raising $67,000 on the popular crowdfunding platform. “We’ve been in ...
(Date:1/18/2017)... ... January 18, 2017 , ... Visually ... number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are ... Dri created this infographic to explain the seven types of hyperhidrosis. This visual ...
(Date:1/18/2017)... (PRWEB) , ... January 18, ... ... specialty pharmacy industry’s leading journal and most-read publication among specialty pharmacists and ... Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, ...
(Date:1/18/2017)... ... January 18, 2017 , ... PrideStaff, a national, ... Franchise Development, Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide ... of top business leaders from across the globe, provides viewers an opportunity to ...
(Date:1/18/2017)... ... ... At Hallmark Nameplate, their commitment to quality is what sets them apart. The company ... is another way they are making constant strides to provide all customers with the ... ISO 13485 Certification is a major accomplishment for Hallmark Nameplate and will allow the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017   Synthetic Biologics, Inc. (NYSE ... designed to preserve the microbiome to protect and ... to initiate a Phase 2b/3 adaptive pivotal trial ... lactone designed to reduce methane production by certain ... to treat the underlying cause of irritable bowel ...
(Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
(Date:1/18/2017)... PHILADELPHIA , Jan. 18, 2017 The Philadelphia ... three companies developing medical devices for children. The Consortium ... to receive seed grants of $50,000 each. The ... amplifies weak nerve signals, a hand-operated rapid blood delivery system ... ears in babies. ...
Breaking Medicine Technology: